Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Evaluation of Antileishmanial Effect of Hydroalcoholic Extract of Ganoderma Leucidum on Leishmania Major in Vitro Publisher



Akbari S1 ; Chabavizadeh J1 ; Abtahi SM1 ; Yegdaneh A1 ; Namdar F2 ; Saberi S1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Mycology and Parasitology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2019


Abstract

Background: Leishmania major is the causative agent of cutaneous leishmaniasis in Iran. Because of the side effects of current drugs and the emergence of drug resistance in some areas, researchers have been seeking for more effective and non-complicated compounds, especially herbal medicines and natural compounds, for the treatment of leishmaniasis. The aim of this study was to evaluate the antileishmanial effect of hydroalcoholic extract of Ganoderma leucidum on Leishmania major compared to commonly used drugs. Methods: Iranian Leishmania major parasite species (MRHO/IR/75/ER) was cultured in Novy-Mac Neal-Nicolle (NNN) and Roswell Park Memorial Institute-1640 (RPMI)-enriched media, and in the metacyclic phase transferred to a 96-well plate at the time of preparation of the hydroalcoholic extracts. Then, concentrations of 10, 50, 100, 150, and 200 µg/ml were used at 24, 48, and 72 hours. The amount of live promastigotes was assessed by using a hemocytometer and MTT colorimetric assay. Data were analyzed using Kolmogorov-Simonov, ANOVA, and repeated measures ANOVA tests, and P < 0.05 was considered as a meaningful level. Findings: The hydroalcoholic extract of this mushroom at high concentrations (150 and 200 µg/ml) inhibited the growth of the parasite significantly, and had a direct correlation with the increase of time (P < 0.001). Moreover, in the MTT method, it was a significant difference in the mean of optical absorption of different extract concentrations at 24, 48, and 72 hours (P < 0.001). Conclusion: The observed antileishmanial effect of Ganoderma leucidum extract on the number and growth of live promastigotes at high concentrations can be resulted due to its compounds such as tannins, flavonoids, triterophenides, and polysaccharides. It requires further research on the purification of its compounds and work on the animal model of Leishmaniasis. © 2019, Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. In Vitro Anti-Leishmanial Activity of Satureja Hortensis and Artemisia Dracunculus Extracts on Leishmania Major Promastigotes, Journal of Parasitic Diseases (2016)
2. In Vitro Antileishmanial Activity of Falcaria Vulgaris Fractions on Leishmania Major, Jundishapur Journal of Natural Pharmaceutical Products (2017)
3. Anti-Leishmanial Effects of Eryngium Planum and Ecbilliun Elaterum Methanolic Extract Against Leishmania Major, AMB Express (2024)
4. Treatment Role of Terpenoid Fraction of Perovskia Abrotanoides Kar. on Zoonotic Cutaneous Leishmaniasis in Animal Model, Traditional and Integrative Medicine (2022)
5. Comparision Effectivness of Extracts of Thyme, Yarrow, Henna and Garlic on Cutaneous Leishmaniasis Caused by L. Major in Animal Model (Balb/C), Journal of Medicinal Plants (2009)
6. Treatment of Recurrent Cutaneous Leishmaniasis, International Journal of Dermatology (1995)
7. Antimonial Treatment Failure Rate in Patients With Cutaneous Leishmaniasis, Tehran University Medical Journal (2018)
8. Butanol Fraction of Kelussia Odoratissima Mozaff Inhibits the Growth of Leishmania Major Promastigote and Amastigote, World's Veterinary Journal (2020)
Experts (# of related papers)
View all Related Experts
Seyed Hossein Hejazi (48)
Sedighe Saberi (16)
Other Related Docs
9. Comparison of Thymus Vulgaris (Thyme), Achillea Millefolium (Yarrow) and Propolis Hydroalcoholic Extracts Versus Systemic Glucantime in the Treatment of Cutaneous Leishmaniasis in Balb/C Mice, Journal of Vector Borne Diseases (2008)
10. In Vitro Effects of Turmeric and Licorice Total Extracts on L. Major Promastigotes, Journal of Isfahan Medical School (2012)
11. In Vitro Study of the Leishmanicidal Activity of Perovskia Abrotanoides Terpenoid-Rich Fractions Against Leishmania Major (Mrho/Ir/75/Er), Advanced Biomedical Research (2023)
12. The Study of the Inhibitory Effects of Aqueous and Ethanolic Extracts of Ziziphora Tenuior L. on the Proliferation of Leishmania Major Amastigotes, Iranian Journal of Dermatology (2018)
13. Effects of S-Allyl-Cysteine on Survival, Apoptosis, and Proliferation of Leishmania Major in Vitro, Journal of Isfahan Medical School (2013)
14. A Comparative Study Between the Efficacy of Systemic Meglumine Antimoniate Therapy With Standard or Low Dose Plus Oral Omeprazole in the Treatment of Cutaneous Leishmaniasis, Journal of Vector Borne Diseases (2008)
15. Efficacy of Adjunctive Topical Liposomal Clarithromycin on Systemic Glucantime in Old World Cutaneous Leishmaniasis: A Pilot Clinical Study, Frontiers in Pharmacology (2023)
16. Identification and Phylogenic Analysis of Leishmania Species Among Patients and Reservoir Hosts Based on N-Acetylglucosamine-1-Phosphate Transferase Gene in Central Iran, Annals of Parasitology (2022)
17. Comparison of Three Different Therapies for Cutaneous Leishmaniasis and Identification of the Etiologic Isolates in Isfahan, Iran, Archives of Iranian Medicine (2020)
18. Review of the Prevalence and Causes of Antimony Compounds Resistance in Different Societies: Review Article, Tehran University Medical Journal (2017)
19. Effect of Peel and Leaf Extract of Walnut (Juglans Regia L.) on Cutaneous Leishmaniasis Caused by Leishmania Major in Balb/C Mice, Journal of Chemical and Pharmaceutical Sciences (2016)
20. Isolation of Potent Antileishmanial Agents From Artemisia Kermanensis Podlech Using Bioguided Fractionation, Journal of Parasitic Diseases (2023)
21. Antileishmanial Activity of Prenylated Coumarins Isolated From Ferulago Angulata and Prangos Asperula, Research in Pharmaceutical Sciences (2016)
22. The Efficacy of Intralesional Meglumine Antimoniate (Glucantime) Versus a Combination of Topical Trichloroacetic Acid 50% and Local Heat Therapy by Non-Ablative Radiofrequency on Cutaneous Leishmaniasis Lesions, Journal of Isfahan Medical School (2012)
23. Investigating in Vitro Anti-Leishmanial Effects of Silibinin and Silymarin on Leishmania Major, Annals of parasitology (2018)
24. Development of Liposomes Loaded With Anti-Leishmanial Drugs for the Treatment of Cutaneous Leishmaniasis, Journal of Liposome Research (2013)
25. Effect of Combination Therapy With Systemic Glucantime and Pentoxifylline in the Treatment of Cutaneous Leishmaniasis, International Journal of Dermatology (2006)
26. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Itraconazole in the Treatment of Cutaneous Leishmaniasis, Journal of the European Academy of Dermatology and Venereology (2005)
27. Evaluation of Leishmanicidal Activity of Oxypeucedanin and Isoimperatorin on Leishmania Major Promastigotes, Journal of Isfahan Medical School (2013)
28. Preparation and Evaluation of Clinical Effects of Glucantime Gel Mask, Journal of Isfahan Medical School (2013)
29. The Effectiveness of Mix Extracts of Thyme, Yarrow and Propolis on Cutaneous Leishmaniasis: A Comparative Study in Animal Model (Balb/C), Tehran University Medical Journal (2009)
30. The Therapeutic Effect of Ozonated Olive Oil Plus Glucantime on Human Cutaneous Leishmaniasis, Iranian Journal of Basic Medical Sciences (2019)
31. A Comparison Between the Effects of Glucantime, Topical Trichloroacetic Acid 50% Plus Glucantime, and Fractional Laser Plus Glucantime on Cutaneous Leishmaniasis Lesions, Journal of Isfahan Medical School (2013)
32. Therapeutic Effect of Topical Tamoxifen in Murine Cutaneous Leishmaniasis Caused by Leishmania Major, Antimicrobial Agents and Chemotherapy (2024)
33. Treatment of Cutaneous Leishmaniasis: Cassia Fistula Fruit Gel-Intralesional Glucantime Vs. Placebo Gel- Intralesional Glucantime Combination, Tehran University Medical Journal (2010)
34. Topical Effectiveness of Different Concentrations of Nanosilver Solution on Leishmania Major Lesions in Balb/C Mice, Journal of Vector Borne Diseases (2012)
35. Identification of Leishmania Species and Treatment Courses in Patients With Leishmaniasis in Isfahan, Iran, Journal of Isfahan Medical School (2012)
36. Treatment of Acute Cutaneous Leishmaniasis With Intralesional Injection of Meglumine Antimoniate: Comparison of Conventional Technique With Mesotherapy Gun, International Journal of Dermatology (2010)
37. The Effect of Intralesional Meglumine Antimoniate (Glucantime) Versus a Combination of Topical Trichloroacetic Acid 50% and Local Heat Therapy by Non-Ablative Radiofrequency on Cutaneous Leishmaniasis Lesions, Journal of Research in Medical Sciences (2012)
38. Pcr-Rflp Diagnosis and Characterization of Leishmania Species Causing Human Cutaneous Leishmaniasis and Evaluation of Treatment Times With Glucantime in These Patients, Tropical Biomedicine (2016)
39. Evaluation of the 11-Year Trend of Cutaneous Leishmaniasis in Six Main Foci of the Disease in Isfahan Province During the Years 2008 to 2018, Journal of Isfahan Medical School (2022)
40. Anti-Leishmanial Effects of Resveratrol and Resveratrol Nanoemulsion on Leishmania Major, BMC Microbiology (2022)
41. Comparative Molecular Epidemiology of Leishmania Major and Leishmania Tropica by Pcr-Rflp Technique in Hyper Endemic Cities of Isfahan and Bam, Iran, Case Reports and Clinical Practice Review (2010)
42. Bacterial Superinfection in Zoonotic Cutaneous Leishmaniasis, Medical Science Monitor (2012)
43. The Characterization and Antileishmanial Evaluation on Leishmania Major With Chitosan/Zno Bio-Nanocomposite As Drug Delivery Systems, Nanomedicine Research Journal (2022)
44. Electrocardiographic Changes in Patients With Cutaneous Leishmaniasis Treated With Systemic Glucantime, Annals of the Academy of Medicine Singapore (2008)
45. The Efficacy of 5% Trichloroacetic Acid Cream in the Treatment of Cutaneous Leishmaniasis Lesions, Journal of Dermatological Treatment (2012)
46. Heat Therapy for Cutaneous Leishmaniasis: A Literature Review, Journal of Research in Medical Sciences (2021)
47. The Skin Side Effects of Topical Glucantime in Patients With Cutaneous Leishmaniasis, Journal of Isfahan Medical School (2015)
48. Effect of Adjunctive Topical Liposomal Azithromycin on Systemic Azithromycin on Old World Cutaneous Leishmaniasis: A Pilot Clinical Study, Iranian Journal of Pharmaceutical Research (2021)
49. Effect of Topical Honey Application Along With Intralesional Injection of Glucantime in the Treatment of Cutaneous Leishmaniasis, BMC Complementary and Alternative Medicine (2007)
50. Identification of Leishmania Isolates From Healing and Nonhealing Cutaneous Leishmaniasis Patients Using Internal Transcribed Spacer Region Pcr, Jundishapur Journal of Microbiology (2014)